Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Investments include the installation of development and analytical equipment to support the development of highly potent APIs as well as a new 2800-liter hydrogenator and 1500-mm diameter centrifuge for increased flexibility and capacity within the manufacturing plant.


Cambrex Invests in Generic API Development and Manufacturing Capabilities at its Milan Site

The collaboration will focus on developing a novel and differentiated challenge model for respiratory syncytial virus.


SGS and Bavarian Nordic Form Vaccine Pact

CordenPharma will integrate the Hospira Boulder API manufacturing facility into the CordenPharma Colorado network for highly potent and oncology APIs. 

CordenPharma Acquires Pfizer API Manufacturing Facility in Boulder, Colorado

Hitachi Chemical Advanced Therapeutics Solutions will expand its PCT service platform for cell therapy by adding GMP manufacturing and cleanroom capacity in Allendale, NJ.

Hitachi Chemical Advanced Therapeutics Solutions Expands Cell Therapy Manufacturing Infrastructure

Under an agreement, ProBioGen will develop a stable cell-line for and manufacture an anti-cancer antibody for Chiome using its proprietary cancer cell-killing technology.

ProBioGen and Chiome in Antibody Manufacturing Deal

Cytel, a biometrics CRO and clinical trial software provider, announced that it will be adding a new location for clinical development in Basel, Switzerland. 

Cytel Adds New Clinical Software Site

PCI Pharma Services, a pharmaceutical outsourcing services provider, will acquire Millmount Healthcare, a pharmaceutical and healthcare contract packaging services provider, to expand its European services.

PCI Pharma Services to Acquire Millmount Healthcare

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

CDMOs have established strategies for handling new chemical entities with unknown biological activity.

Managing Potentially Potent APIs

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Mergers and acquisitions are positive for the CDMO industry, but there is a downside.

Up and Away, M&A

The acquisition broadens the CDMO’s preclinical and clinical offering to include bioanalytical and drug discovery services. 